Improved scientific advice for medicines for public health threats including antimicrobial resistance

Human medicines European public assessment report (EPAR): Ivabradine Anpharm, ivabradine, Date of authorisation: 08/09/2015, Revision: 11, Status: Authorised

Emergency Task Force (ETF) recommendations

Parallel scientific advice and special development aspects or product types

Scientific advice and protocol assistance

Scientific advice for public health emergencies and threats

Guidance for applicants: the ETF scientific advice that facilitates clinical trial authorisations (SA-CTA)

Human medicines European public assessment report (EPAR): Corlentor, ivabradine, Date of authorisation: 25/10/2005, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Procoralan, ivabradine, Date of authorisation: 25/10/2005, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR): Imreplys, sargramostim, Date of authorisation: 21/08/2025, Status: Authorised